Clinical Trial Update: Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating adverse events of oral atogepant in adult Chinese participants who completed a prior study, in order to prevent chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Atogepant (Atogepant)

Snippet

Sponsor: Allergan | Conditions: Chronic Migraine | Phase 3 | Status: COMPLETED | Results posted: 2023-05-24